Stay updated on Optimal Tenecteplase Dose in Stroke Clinical Trial
Sign up to get notified when there's something new on the Optimal Tenecteplase Dose in Stroke Clinical Trial page.

Latest updates to the Optimal Tenecteplase Dose in Stroke Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now includes a consolidated Locations section with New South Wales, Queensland, South Australia, Victoria, and Auckland, replacing previous separate location headings; this changes how sites are listed on the page.SummaryDifference0.5%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedPubMed-derived publications note updated to clarify that entries are automatically filled from PubMed and may not all pertain to the study, and the page shows Revision: v3.3.2.SummaryDifference0.1%

- Check46 days agoChange DetectedRemoved the government funding/status notice that previously appeared on the page. The change removes a site-wide status message and does not affect the study details, eligibility criteria, or outcomes.SummaryDifference0.3%

- Check60 days agoChange DetectedThe page content remains substantively the same, with only minor formatting or layout adjustments evident in the screenshots.SummaryDifference0.3%

- Check88 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference3%

- Check96 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes provided.SummaryDifference0.1%

Stay in the know with updates to Optimal Tenecteplase Dose in Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Optimal Tenecteplase Dose in Stroke Clinical Trial page.